Safety and efficacy of rituximab in refractory noninfectious uveitis and scleritis
Rituximab is an effective and safe treatment for refractory noninfectious uveitis and scleritis. It offers significant visual improvement, disease quiescence which potentially reduces reliance on corticosteroids and immunomodulatory therapy.
Authors
- Marwan A. Abouammoh (ORCID: https://orcid.org/0000-0002-0020-8069)
- Ahmed M. Abu El-Asrar
- Faris M. Al Ghulaiga
- Abdulrahman F. AlBloushi (ORCID: https://orcid.org/0000-0003-1104-9208)
- Ibrahim Alharbi (ORCID: https://orcid.org/0009-0003-4150-6307)
- Abdulsalam M. Dheyab
Institutions
- King Saud University (SA)
Publication Details
- Journal
- Journal of Ophthalmic Inflammation and Infection
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1186/s12348-025-00522-5
- Citations
- 1
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 1.71
Funders
- King Saud University